Search Results - "Tzakos, A. G."

  • Showing 1 - 12 results of 12
Refine Results
  1. 1

    Molecular requirements involving the human platelet protease-activated receptor-4 mechanism of activation by peptide analogues of its tethered-ligand by Moschonas, I. C., Kellici, T. F., Mavromoustakos, T., Stathopoulos, P., Tsikaris, V., Magafa, V., Tzakos, A. G., Tselepis, A. D.

    Published in Platelets (Edinburgh) (17-11-2017)
    “…Thrombin is the most potent agonist of human platelets and its effects are primarily mediated through the protease-activated receptors (PARs)-1 and -4…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Structure and function of the myelin proteins: current status and perspectives in relation to multiple sclerosis by Tzakos, Andreas G, Troganis, Anastassios, Theodorou, Vassiliki, Tselios, Theodore, Svarnas, Christos, Matsoukas, John, Apostolopoulos, Vasso, Gerothanassis, Ioannis P

    Published in Current medicinal chemistry (01-01-2005)
    “…Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system (CNS) characterized by demyelination and loss of neurological function,…”
    Get more information
    Journal Article
  4. 4
  5. 5

    Cyanobacterial cyclopeptides as lead compounds to novel targeted cancer drugs by Sainis, Ioannis, Fokas, Demosthenes, Vareli, Katerina, Tzakos, Andreas G, Kounnis, Valentinos, Briasoulis, Evangelos

    Published in Marine drugs (15-03-2010)
    “…Cyanobacterial cyclopeptides, including microcystins and nodularins, are considered a health hazard to humans due to the possible toxic effects of high…”
    Get full text
    Journal Article Book Review
  6. 6

    Complementary Segmental Labeling of Large RNAs:  Economic Preparation and Simplified NMR Spectra for Measurement of More RDCs by Tzakos, Andreas G, Easton, Laura E, Lukavsky, Peter J

    Published in Journal of the American Chemical Society (18-10-2006)
    “…NMR structure determination of large RNAs is often restricted by limited RDC information caused by chemical shift degeneracy. We established a general, time-…”
    Get full text
    Journal Article
  7. 7

    Domain-Selective Ligand-Binding Modes and Atomic Level Pharmacophore Refinement in Angiotensin I Converting Enzyme (ACE) Inhibitors by Tzakos, Andreas G, Gerothanassis, Ioannis P

    “…Somatic ACE (EC 3.4.15.1), a ZnII metalloproteinase, is composed of functionally active N and C domains resulting from tandem gene duplication. Despite the…”
    Get full text
    Journal Article
  8. 8

    On the structural basis of the hypertensive properties of angiotensin II: a solved mystery or a controversial issue? by Tzakos, Andreas G, Gerothanassis, Ioannis P, Troganis, Anastassios N

    Published in Current topics in medicinal chemistry (01-01-2004)
    “…Angiotensin II (AII), Asp1-Arg2-Val3-Tyr4-Ile5-His6-Pro7-Phe8, the primary active hormone of the Renin-Angiotensin-System (RAS), is a major vasoconstrictor…”
    Get more information
    Journal Article
  9. 9

    NMR techniques for very large proteins and rnas in solution by Tzakos, Andreas G, Grace, Christy R R, Lukavsky, Peter J, Riek, Roland

    “…Three-dimensional structure determination of small proteins and oligonucleotides by solution NMR is established. With the development of novel NMR and labeling…”
    Get full text
    Journal Article
  10. 10

    NMR and molecular dynamics studies of an autoimmune myelin basic protein peptide and its antagonist by Tzakos, Andreas G., Fuchs, Patrick, van Nuland, Nico A. J., Troganis, Anastasios, Tselios, Theodore, Deraos, Spyros, Matsoukas, John, Gerothanassis, Ioannis P., Bonvin, Alexandre M. J. J.

    Published in European journal of biochemistry (01-08-2004)
    “…Experimental autoimmune encephalomyelitis can be induced in susceptible animals by immunodominant determinants of myelin basic protein (MBP). To characterize…”
    Get full text
    Journal Article
  11. 11
  12. 12